PREVNAR 20 (pneumococcal 20-valent conjugate vaccine (Diphtheria crm)/PF)
PNEUMOCOCCAL VACCINES · STREPTOCOCCUS PNEUMONIAE VACCINATION
Wyeth Pharmaceutical
Drug class
Pneumococcal Vaccines
Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae*. Read more about Pneumococcal Vaccines
10 drugs in this class 3 manufacturers
Drugs in Pneumococcal Vaccines
Filter & compare in the drug finder →
Opens the drug finder with Pneumococcal Vaccines preselected. Add indication or manufacturer filters there.
Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae*.
They function by exposing the host immune system to capsular polysaccharides—either alone or conjugated to an immunogenic carrier protein to elicit a T-cell–dependent response—thereby stimulating the production of serotype-specific protective antibodies and immunological memory.
Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations.
-
fda.gov
Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae*
-
fda.gov
Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae* Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations
-
cdc.gov
Pneumococcal vaccines are an immunization class comprising pneumococcal conjugate and pneumococcal polysaccharide formulations designed to induce active immunity against *Streptococcus pneumoniae*
-
fda.gov
They function by exposing the host immune system to capsular polysaccharides—either alone or conjugated to an immunogenic carrier protein to elicit a T-cell–dependent response—thereby stimulating the production of serotype-specific protective antibodies and immunological memory
-
fda.gov
Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations
-
fda.gov
Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations
-
fda.gov
Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations
-
cdc.gov
Clinically, these vaccines are indicated to prevent invasive pneumococcal disease, including bacteremia, sepsis, and meningitis, as well as localized respiratory manifestations such as pneumococcal pneumonia and acute otitis media across routine pediatric, older adult, and high-risk populations
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.